Moderna Total Current Assets decreased by 11.8% to $5.77B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.7%, from $6.77B to $5.77B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows relatively stable performance with a 0.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.97B | $13.43B | $16.07B | $16.35B | $13.56B | $14.30B | $13.43B | $12.12B | $10.60B | $10.80B | $10.33B | $9.60B | $9.66B | $9.67B | $8.10B | $6.77B | $6.17B | $6.60B | $6.54B | $5.77B |
| QoQ Change | — | +22.4% | +19.7% | +1.7% | -17.0% | +5.4% | -6.1% | -9.7% | -12.6% | +1.9% | -4.4% | -7.0% | +0.6% | +0.1% | -16.2% | -16.5% | -8.8% | +6.9% | -0.8% | -11.8% |
| YoY Change | — | — | — | — | +23.6% | +6.5% | -16.4% | -25.9% | -21.9% | -24.5% | -23.1% | -20.8% | -8.8% | -10.5% | -21.6% | -29.5% | -36.1% | -31.7% | -19.2% | -14.7% |